Insider: Holmlin R. Erik President and CEO - BioNano Genomics, Inc
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 806,474 | 2,200 | 808,674 |
| Value | $1,338,746.84 | $3,652.00 | $1,342,398.84 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/16/2023 | AAP | 15,000 | Direct | COM | $0.64 | $9,639.00 | 806,474 |
| 11/29/2021 | AAP | 2,200 | Indirect | COM | $3.99 | $8,767.00 | 2,200 |
| 11/29/2021 | AAP | 2,675 | Indirect | COM | $3.99 | $10,673.25 | 4,875 |
| 11/29/2021 | AAP | 150 | Indirect | COM | $3.98 | $597.00 | 5,025 |
| 08/23/2018 | AAP | 1,630 | Direct | COM | $6.13 | $9,983.75 | 1,630 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research